EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study

Shuixiang Tao, Yiwei Lin, Shengqiang Huang, Shen Lin, Ke Jin, Hong Chen iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Shuixiang Tao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shaoxing People's Hospital (Zhejiang University Shaoxing Hospital), Shaoxing, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Medical and Health Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Currently there is no specific molecular biomarker for the diagnosis and treatment of renal cell carcinoma (RCC). Here we performed a gender‐specific two‐sample Mendelian randomization analysis to systematically assess the effects of circulating cytokines on RCC.

Methods

We have employed cis‐quantitative trait loci as instrumental variables for the protein levels and expression of circulating cytokines. We estimated the causal effects of circulating cytokines on RCC risk in males and females with several Mendelian randomization methods.

Results

We observed a significant causal effect of Eotaxin on the increased risk of RCC in males (Odds ratio [OR] = 2.546, 95% confidence interval [CI] = 1.617–4.010, p value = 5.496 × 10–5), but not in females (OR = 1.352, 95% CI = 0.766–2.388, p value = 0.298). Besides, we also identified several cytokines as potentially associated with RCC in males including RANTES, MCP3, PDGFbb, TRAIL, and several other cytokines as potentially associated with RCC in females including sICAM and SCGFb.

Conclusion

Our study highlighted that a higher level of circulating Eotaxin is causally associated with an increased risk of RCC in males but not in females. Further studies are needed to elucidate the exact mechanism and its potential application in the prognosis and treatment of RCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsMaleFemaleHumansCytokinesMendelian Randomization AnalysisGenome-Wide Association StudyPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

EotaxinMendelian randomizationcytokinesrenal cell carcinoma

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Urology, Shaoxing People's Hospital (Zhejiang University Shaoxing Hospital), Shaoxing, Zhejiang, China.
  • Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Urology, The People's Hospital of Pujiang County, Jinhua, Zhejiang, China.

ORCID-Profile: Hong Chen

Förderung

  • Zhejiang Medical and Health Science and Technology Project

Zitieren

APA

Tao, S., Lin, Y., Huang, S., Lin, S., Jin, K., & Chen, H. (2023). Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study. Cancer Medicine. https://doi.org/10.1002/cam4.6658

Vancouver

Tao S, Lin Y, Huang S, Lin S, Jin K, Chen H. Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study. Cancer Medicine. 2023. doi:10.1002/cam4.6658

BibTeX
@article{Tao2023,
  author = {Tao, Shuixiang and Lin, Yiwei and Huang, Shengqiang and Lin, Shen and Jin, Ke and Chen, Hong},
  title = {Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6658}
}
Kostenlos starten →